These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16461830)

  • 1. Arterial stiffness, vascular disease, and risk of cardiovascular events.
    Cohn JN
    Circulation; 2006 Feb; 113(5):601-3. PubMed ID: 16461830
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD.
    Zoungas S; Cameron JD; Kerr PG; Wolfe R; Muske C; McNeil JJ; McGrath BP
    Am J Kidney Dis; 2007 Oct; 50(4):622-30. PubMed ID: 17900462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotid intima-media thickness and the risk of new vascular events in patients with manifest atherosclerotic disease: the SMART study.
    Dijk JM; van der Graaf Y; Bots ML; Grobbee DE; Algra A
    Eur Heart J; 2006 Aug; 27(16):1971-8. PubMed ID: 16835264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic plaque psoriasis is associated with increased arterial stiffness.
    Gisondi P; Fantin F; Del Giglio M; Valbusa F; Marino F; Zamboni M; Girolomoni G
    Dermatology; 2009; 218(2):110-3. PubMed ID: 19060461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.
    Dennison CR; Hughes S
    J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for peripheral arterial disease.
    Grøndal N; Lindholt JS
    Eur J Vasc Endovasc Surg; 2009 Sep; 38(3):314-5. PubMed ID: 19560376
    [No Abstract]   [Full Text] [Related]  

  • 7. [Risk factors of cardiovascular diseases in patients with rheumatoid arthritis].
    Rebrov AP; Nikitina NM
    Klin Med (Mosk); 2008; 86(2):56-9. PubMed ID: 18368795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the impact of hepatitis C virus on insulin resistance and arterial stiffness in hemodialysis patients.
    Adam FU; Torun D; Yigit F; Ozelsancak R; Sezer S; Ozdemir FN; Haberal M
    Ren Fail; 2008; 30(4):411-5. PubMed ID: 18569915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of (a)symptomatic peripheral arterial disease; the additional value of ankle-brachial index on cardiovascular risk stratification.
    van Kuijk JP; Flu WJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2009 Sep; 38(3):312-3. PubMed ID: 19524459
    [No Abstract]   [Full Text] [Related]  

  • 10. Infliximab improves vascular stiffness in patients with rheumatoid arthritis.
    Wong M; Oakley SP; Young L; Jiang BY; Wierzbicki A; Panayi G; Chowienczyk P; Kirkham B
    Ann Rheum Dis; 2009 Aug; 68(8):1277-84. PubMed ID: 18930987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial stiffness: a modifiable cardiovascular risk factor?
    O'Rourke MF; Hashimoto J
    J Cardiopulm Rehabil Prev; 2008; 28(4):225-37. PubMed ID: 18628652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifestyle, cardio-metabolic risk and arterial stiffness.
    Duda-Seiman DM; Mancaş S; Gaită D; Drăgan S; Velimirovici D; Iurciuc S; Sarău CA; Iurciuc M; Rada M; Petcov B
    Rom J Intern Med; 2008; 46(1):39-45. PubMed ID: 19157269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk.
    Ramos R; Quesada M; Solanas P; Subirana I; Sala J; Vila J; Masiá R; Cerezo C; Elosua R; Grau M; Cordón F; Juvinyà D; Fitó M; Isabel Covas M; Clarà A; Angel Muñoz M; Marrugat J;
    Eur J Vasc Endovasc Surg; 2009 Sep; 38(3):305-11. PubMed ID: 19515589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders.
    Guérin AP; Pannier B; Marchais SJ; London GM
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):105-10. PubMed ID: 16481874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and cardiovascular risk. Vijay Nambi speaks to Christine Forder, commissioning editor.
    Nambi V
    Future Cardiol; 2009 Mar; 5(2):121-3. PubMed ID: 19371186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease.
    Hajer GR; van der Graaf Y; Olijhoek JK; Edlinger M; Visseren FL
    Am Heart J; 2007 Oct; 154(4):750.e1-7. PubMed ID: 17893004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of arterial structure and function: towards new biomarkers for aortic stiffness?
    Yasmin ; O'Shaughnessy KM
    Clin Sci (Lond); 2008 Jun; 114(11):661-77. PubMed ID: 18442360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk can be represented by scaled rectangle diagrams.
    Marshall RJ
    J Clin Epidemiol; 2009 Sep; 62(9):998-1000. PubMed ID: 19635404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular stiffness: its measurement and significance for epidemiologic and outcome studies.
    DeLoach SS; Townsend RR
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):184-92. PubMed ID: 18178784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
    Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.